Developing gene and cell therapies for rare diseases: an opportunity for synergy between academia and industry
Crossref DOI link: https://doi.org/10.1038/gt.2017.36
Published Online: 2017-05-25
Published Print: 2017-09
Update policy: https://doi.org/10.1007/springer_crossmark_policy
Mavilio, F http://orcid.org/0000-0003-0459-4320
Text and Data Mining valid from 2017-05-25
Version of Record valid from 2017-05-25
Article History
Received: 19 February 2017
Revised: 25 April 2017
Accepted: 28 April 2017
First Online: 25 May 2017
Competing interests
: The author declares no conflict of interest.